What is cefoperazone used to treat?
Pharmaceutical Product Monograph: Cefoperazone Sodium (1 g)
In the pharmaceutical industry, Cefoperazone is a parenteral, semi-synthetic Third-Generation Cephalosporin antibiotic. As a pharmacist and manufacturer, I view this molecule as the “Biliary Specialist”—it is technically unique because, unlike most other cephalosporins, it is primarily excreted through the bile (liver) rather than the kidneys. This makes it an essential tool for treating infections in patients with renal failure.
At your WHO-GMP facility in Mumbai, Cefoperazone is a high-volume SKU, often manufactured in a 1:1 or 2:1 ratio with Sulbactam to overcome bacterial resistance.
Therapeutic Profile: Primary Indications
Cefoperazone is indicated for a broad range of severe infections, with a particular focus on the gastrointestinal and biliary systems.
| Indication | Clinical Context | Technical Rationale |
| Biliary Tract Infections | Cholecystitis / Cholangitis | Gold Standard: Reaches concentrations in the bile 8–10 times higher than in the blood. |
| Peritonitis | Intra-abdominal Sepsis | Effective against a wide array of aerobic and anaerobic organisms found in the gut. |
| Pseudomonal Infections | HAP / VAP | One of the few 3rd-gen cephalosporins with significant activity against Pseudomonas aeruginosa. |
| Respiratory Tract | Severe Pneumonia | Used in hospitalized patients with multi-drug resistant (MDR) lung infections. |
| Septicemia | Bloodstream Infection | Used as empirical therapy for patients showing signs of systemic shock. |
Mechanism: Cell Wall Transpeptidase Inhibition
Cefoperazone works by sabotaging the structural integrity of the bacterial cell wall during the growth phase:
PBP Affinity: The drug binds to Penicillin-Binding Proteins (PBPs) on the inner bacterial membrane.
Peptidoglycan Blockade: It inhibits the final cross-linking step (transpeptidation) of cell wall synthesis.
Bacterial Lysis: Technically, this creates a “weak” cell wall that cannot withstand the bacteria’s internal osmotic pressure, causing the cell to burst and die.
The Pharmacist’s “Technical Warning”
The “Disulfiram” Interaction: As a pharmacist, I must warn that Cefoperazone contains an MTT side chain. If a patient consumes alcohol during or up to 72 hours after treatment, they will experience severe nausea, vomiting, and tachycardia (Disulfiram-like reaction).
The “Vitamin K” Risk: The same MTT side chain can technically interfere with Vitamin K metabolism, leading to a risk of bleeding. High-risk patients may require Vitamin K supplements during therapy.
The “No Renal Adjustment” Rule: Because it is excreted via the liver, no dose reduction is technically required for patients with Kidney Failure, making it a very safe “Renal-Friendly” antibiotic.
Sulbactam Synergy: If you are using the Cefoperazone-Sulbactam combination, the Sulbactam technically “protects” the Cefoperazone from being eaten by bacterial enzymes (Beta-lactamases).
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Hygroscopic” USP: On your digital marketplace, highlight your Advanced Moisture-Proof Sealing. Cefoperazone Sodium is highly hygroscopic (absorbs water from the air). Your Aseptic Filling Line ensures the powder remains free-flowing and stable for a 24-month shelf life.
The “Cold Chain” Optionality: While stable at room temperature in many regions, for Zone IVb (Tropical) exports, we recommend storage below $25^\circ\text{C}$ to prevent “browning” of the powder.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Cefoperazone 1 g and Cefoperazone-Sulbactam 1.5 g / 2 g to support your registration in international B2B tenders for gastrointestinal and critical care.